BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15351965)

  • 1. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection.
    Storkebaum E; Lambrechts D; Carmeliet P
    Bioessays; 2004 Sep; 26(9):943-54. PubMed ID: 15351965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.
    Lambrechts D; Carmeliet P
    Biochim Biophys Acta; 2006; 1762(11-12):1109-21. PubMed ID: 16784838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
    Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
    Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.
    Oosthuyse B; Moons L; Storkebaum E; Beck H; Nuyens D; Brusselmans K; Van Dorpe J; Hellings P; Gorselink M; Heymans S; Theilmeier G; Dewerchin M; Laudenbach V; Vermylen P; Raat H; Acker T; Vleminckx V; Van Den Bosch L; Cashman N; Fujisawa H; Drost MR; Sciot R; Bruyninckx F; Hicklin DJ; Ince C; Gressens P; Lupu F; Plate KH; Robberecht W; Herbert JM; Collen D; Carmeliet P
    Nat Genet; 2001 Jun; 28(2):131-8. PubMed ID: 11381259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.
    Lambrechts D; Storkebaum E; Morimoto M; Del-Favero J; Desmet F; Marklund SL; Wyns S; Thijs V; Andersson J; van Marion I; Al-Chalabi A; Bornes S; Musson R; Hansen V; Beckman L; Adolfsson R; Pall HS; Prats H; Vermeire S; Rutgeerts P; Katayama S; Awata T; Leigh N; Lang-Lazdunski L; Dewerchin M; Shaw C; Moons L; Vlietinck R; Morrison KE; Robberecht W; Van Broeckhoven C; Collen D; Andersen PM; Carmeliet P
    Nat Genet; 2003 Aug; 34(4):383-94. PubMed ID: 12847526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
    Azzouz M; Ralph GS; Storkebaum E; Walmsley LE; Mitrophanous KA; Kingsman SM; Carmeliet P; Mazarakis ND
    Nature; 2004 May; 429(6990):413-7. PubMed ID: 15164063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
    Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
    Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vascular endothelial growth factor (VEGF) on motor neuron degeneration.
    Van Den Bosch L; Storkebaum E; Vleminckx V; Moons L; Vanopdenbosch L; Scheveneels W; Carmeliet P; Robberecht W
    Neurobiol Dis; 2004 Oct; 17(1):21-8. PubMed ID: 15350962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
    Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor attenuates neurodegenerative changes in the NSC-34 motor neuron cell line induced by cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients.
    Kulshreshtha D; Vijayalakshmi K; Alladi PA; Sathyaprabha TN; Nalini A; Raju TR
    Neurodegener Dis; 2011; 8(5):322-30. PubMed ID: 21389676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
    Lambrechts D; Storkebaum E; Carmeliet P
    Trends Mol Med; 2004 Jun; 10(6):275-82. PubMed ID: 15177192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential.
    Zachary I
    Neurosignals; 2005; 14(5):207-21. PubMed ID: 16301836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VEGF as an angiogenic, neurotrophic, and neuroprotective factor].
    Namiecińska M; Marciniak K; Nowak JZ
    Postepy Hig Med Dosw (Online); 2005; 59():573-83. PubMed ID: 16407796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF: a critical player in neurodegeneration.
    Storkebaum E; Carmeliet P
    J Clin Invest; 2004 Jan; 113(1):14-8. PubMed ID: 14702101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.
    Tolosa L; Mir M; Asensio VJ; Olmos G; Lladó J
    J Neurochem; 2008 May; 105(4):1080-90. PubMed ID: 18182045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroprotective mechanisms of vascular endothelial growth factor].
    Wang YQ; Sun FY
    Sheng Li Ke Xue Jin Zhan; 2007 Jul; 38(3):202-7. PubMed ID: 17882975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
    Lambrechts D; Poesen K; Fernández-Santiago R; Al-Chalabi A; Del Bo R; Van Vught PW; Khan S; Marklund SL; Brockington A; van Marion I; Anneser J; Shaw C; Ludolph AC; Leigh NP; Comi GP; Gasser T; Shaw PJ; Morrison KE; Andersen PM; Van den Berg LH; Thijs V; Siddique T; Robberecht W; Carmeliet P
    J Med Genet; 2009 Dec; 46(12):840-6. PubMed ID: 18413368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
    Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
    J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia.
    Kilic E; Kilic U; Wang Y; Bassetti CL; Marti HH; Hermann DM
    FASEB J; 2006 Jun; 20(8):1185-7. PubMed ID: 16641198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor].
    Li SF; Wang RZ; Li GL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):115-9. PubMed ID: 15782506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.